Quest Diagnostics Incorporated (0KSX.L)
USD 177.36
(-0.41%)
USD 177.36
(-0.41%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 9.25 Billion USD | -6.38% |
| 2022 | 9.88 Billion USD | -8.39% |
| 2021 | 10.78 Billion USD | 14.32% |
| 2020 | 9.43 Billion USD | 22.15% |
| 2019 | 7.72 Billion USD | 2.59% |
| 2018 | 7.53 Billion USD | -2.31% |
| 2017 | 7.7 Billion USD | 2.58% |
| 2016 | 7.51 Billion USD | 0.29% |
| 2015 | 7.49 Billion USD | 0.78% |
| 2014 | 7.43 Billion USD | 4.04% |
| 2013 | 7.14 Billion USD | -3.2% |
| 2012 | 7.38 Billion USD | -1.7% |
| 2011 | 7.51 Billion USD | 1.92% |
| 2010 | 7.36 Billion USD | -1.16% |
| 2009 | 7.45 Billion USD | 2.84% |
| 2008 | 7.24 Billion USD | 8.12% |
| 2007 | 6.7 Billion USD | 6.96% |
| 2006 | 6.26 Billion USD | 13.9% |
| 2005 | 5.5 Billion USD | 7.36% |
| 2004 | 5.12 Billion USD | 8.2% |
| 2003 | 4.73 Billion USD | 15.33% |
| 2002 | 4.1 Billion USD | 13.24% |
| 2001 | 3.62 Billion USD | 6.04% |
| 2000 | 3.42 Billion USD | 55.14% |
| 1999 | 2.2 Billion USD | 51.19% |
| 1998 | 1.45 Billion USD | -4.59% |
| 1997 | 1.52 Billion USD | -5.42% |
| 1996 | 1.61 Billion USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 2.36 Billion USD | 3.41% |
| 2024 Q3 | 2.48 Billion USD | 3.8% |
| 2024 Q2 | 2.39 Billion USD | 1.31% |
| 2023 Q4 | 2.28 Billion USD | -0.31% |
| 2023 Q1 | 2.33 Billion USD | -0.09% |
| 2023 FY | 9.25 Billion USD | -6.38% |
| 2023 Q2 | 2.33 Billion USD | 0.3% |
| 2023 Q3 | 2.29 Billion USD | -1.84% |
| 2022 FY | 9.88 Billion USD | -8.39% |
| 2022 Q1 | 2.61 Billion USD | -4.85% |
| 2022 Q2 | 2.45 Billion USD | -6.05% |
| 2022 Q3 | 2.48 Billion USD | 1.35% |
| 2022 Q4 | 2.33 Billion USD | -6.15% |
| 2021 Q4 | 2.74 Billion USD | -1.08% |
| 2021 FY | 10.78 Billion USD | 14.32% |
| 2021 Q1 | 2.72 Billion USD | -9.39% |
| 2021 Q2 | 2.55 Billion USD | -6.25% |
| 2021 Q3 | 2.77 Billion USD | 8.78% |
| 2020 Q2 | 1.82 Billion USD | 0.27% |
| 2020 Q3 | 2.78 Billion USD | 52.49% |
| 2020 Q4 | 3 Billion USD | 7.75% |
| 2020 Q1 | 1.82 Billion USD | -5.4% |
| 2020 FY | 9.43 Billion USD | 22.15% |
| 2019 Q1 | 1.89 Billion USD | 2.83% |
| 2019 Q4 | 1.92 Billion USD | -1.53% |
| 2019 FY | 7.72 Billion USD | 2.59% |
| 2019 Q2 | 1.95 Billion USD | 3.28% |
| 2019 Q3 | 1.95 Billion USD | 0.15% |
| 2018 Q2 | 1.91 Billion USD | 1.86% |
| 2018 Q3 | 1.88 Billion USD | -1.56% |
| 2018 FY | 7.53 Billion USD | -2.31% |
| 2018 Q1 | 1.88 Billion USD | -2.69% |
| 2018 Q4 | 1.83 Billion USD | -2.65% |
| 2017 Q1 | 1.89 Billion USD | 2.04% |
| 2017 Q4 | 1.93 Billion USD | 0.26% |
| 2017 Q3 | 1.93 Billion USD | -0.62% |
| 2017 FY | 7.7 Billion USD | 2.58% |
| 2017 Q2 | 1.94 Billion USD | 2.32% |
| 2016 FY | 7.51 Billion USD | 0.29% |
| 2016 Q3 | 1.88 Billion USD | -1.1% |
| 2016 Q2 | 1.9 Billion USD | 2.31% |
| 2016 Q1 | 1.86 Billion USD | 0.76% |
| 2016 Q4 | 1.86 Billion USD | -1.27% |
| 2015 FY | 7.49 Billion USD | 0.78% |
| 2015 Q4 | 1.84 Billion USD | -1.65% |
| 2015 Q3 | 1.88 Billion USD | -2.34% |
| 2015 Q2 | 1.92 Billion USD | 4.68% |
| 2015 Q1 | 1.83 Billion USD | -2.34% |
| 2014 FY | 7.43 Billion USD | 4.04% |
| 2014 Q2 | 1.9 Billion USD | 8.93% |
| 2014 Q1 | 1.74 Billion USD | -0.57% |
| 2014 Q3 | 1.9 Billion USD | 0.11% |
| 2014 Q4 | 1.88 Billion USD | -1.1% |
| 2013 FY | 7.14 Billion USD | -3.2% |
| 2013 Q4 | 1.75 Billion USD | -1.74% |
| 2013 Q3 | 1.78 Billion USD | -1.58% |
| 2013 Q2 | 1.81 Billion USD | 1.63% |
| 2013 Q1 | 1.78 Billion USD | 0.72% |
| 2012 Q3 | 1.85 Billion USD | -2.91% |
| 2012 Q4 | 1.77 Billion USD | -4.19% |
| 2012 Q2 | 1.9 Billion USD | -1.53% |
| 2012 Q1 | 1.93 Billion USD | 3.04% |
| 2012 FY | 7.38 Billion USD | -1.7% |
| 2011 Q2 | 1.9 Billion USD | 4.48% |
| 2011 Q4 | 1.87 Billion USD | -1.42% |
| 2011 Q3 | 1.9 Billion USD | 0.17% |
| 2011 FY | 7.51 Billion USD | 1.92% |
| 2011 Q1 | 1.82 Billion USD | -0.13% |
| 2010 Q1 | 1.8 Billion USD | -2.31% |
| 2010 FY | 7.36 Billion USD | -1.16% |
| 2010 Q2 | 1.87 Billion USD | 3.83% |
| 2010 Q3 | 1.86 Billion USD | -0.53% |
| 2010 Q4 | 1.82 Billion USD | -2.18% |
| 2009 FY | 7.45 Billion USD | 2.84% |
| 2009 Q1 | 1.8 Billion USD | 0.43% |
| 2009 Q4 | 1.84 Billion USD | -2.58% |
| 2009 Q3 | 1.89 Billion USD | -0.24% |
| 2009 Q2 | 1.9 Billion USD | 5.19% |
| 2008 Q4 | 1.8 Billion USD | -1.44% |
| 2008 Q3 | 1.82 Billion USD | -0.61% |
| 2008 FY | 7.24 Billion USD | 8.12% |
| 2008 Q1 | 1.78 Billion USD | 0.8% |
| 2008 Q2 | 1.83 Billion USD | 2.98% |
| 2007 Q1 | 1.52 Billion USD | -1.49% |
| 2007 Q4 | 1.77 Billion USD | 0.19% |
| 2007 Q3 | 1.76 Billion USD | 7.67% |
| 2007 Q2 | 1.64 Billion USD | 7.53% |
| 2007 FY | 6.7 Billion USD | 6.96% |
| 2006 FY | 6.26 Billion USD | 13.9% |
| 2006 Q4 | 1.54 Billion USD | -2.14% |
| 2006 Q3 | 1.58 Billion USD | -0.07% |
| 2006 Q2 | 1.58 Billion USD | 1.86% |
| 2006 Q1 | 1.55 Billion USD | 8.4% |
| 2005 Q2 | 1.37 Billion USD | 4.4% |
| 2005 Q1 | 1.31 Billion USD | 2.82% |
| 2005 Q4 | 1.43 Billion USD | 4.6% |
| 2005 Q3 | 1.37 Billion USD | -0.41% |
| 2005 FY | 5.5 Billion USD | 7.36% |
| 2004 Q2 | 1.29 Billion USD | 3.34% |
| 2004 FY | 5.12 Billion USD | 8.2% |
| 2004 Q3 | 1.28 Billion USD | -0.6% |
| 2004 Q1 | 1.25 Billion USD | 4.3% |
| 2004 Q4 | 1.28 Billion USD | -0.51% |
| 2003 Q3 | 1.22 Billion USD | 0.11% |
| 2003 Q4 | 1.2 Billion USD | -1.41% |
| 2003 Q2 | 1.21 Billion USD | 11.63% |
| 2003 FY | 4.73 Billion USD | 15.33% |
| 2003 Q1 | 1.09 Billion USD | 5.71% |
| 2002 Q3 | 1.05 Billion USD | -0.94% |
| 2002 FY | 4.1 Billion USD | 13.24% |
| 2002 Q1 | 946.76 Million USD | 3.99% |
| 2002 Q2 | 1.06 Billion USD | 12.89% |
| 2002 Q4 | 1.03 Billion USD | -2.36% |
| 2001 Q3 | 903.18 Million USD | -3.05% |
| 2001 Q4 | 910.44 Million USD | 0.8% |
| 2001 FY | 3.62 Billion USD | 6.04% |
| 2001 Q1 | 882.55 Million USD | 5.53% |
| 2001 Q2 | 931.58 Million USD | 5.56% |
| 2000 Q2 | 877.11 Million USD | 2.29% |
| 2000 Q3 | 850.23 Million USD | -3.06% |
| 2000 Q1 | 857.47 Million USD | 5.28% |
| 2000 FY | 3.42 Billion USD | 55.14% |
| 2000 Q4 | 836.33 Million USD | -1.64% |
| 1999 Q3 | 614.8 Million USD | 56.04% |
| 1999 Q1 | 381.8 Million USD | 5.09% |
| 1999 Q2 | 394 Million USD | 3.2% |
| 1999 FY | 2.2 Billion USD | 51.19% |
| 1999 Q4 | 814.5 Million USD | 32.48% |
| 1998 Q4 | 363.3 Million USD | 0.72% |
| 1998 Q1 | 367.9 Million USD | 0.68% |
| 1998 Q2 | 366.7 Million USD | -0.33% |
| 1998 Q3 | 360.7 Million USD | -1.64% |
| 1998 FY | 1.45 Billion USD | -4.59% |
| 1997 Q4 | 365.4 Million USD | -2.19% |
| 1997 Q1 | 388.1 Million USD | 0.81% |
| 1997 Q2 | 401.5 Million USD | 3.45% |
| 1997 Q3 | 373.6 Million USD | -6.95% |
| 1997 FY | 1.52 Billion USD | -5.42% |
| 1996 Q4 | 385 Million USD | -5.03% |
| 1996 Q3 | 405.4 Million USD | 0.0% |
| 1996 FY | 1.61 Billion USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Phreesia, Inc. | 356.29 Million USD | -2496.695% |
| Accuray Incorporated | 446.55 Million USD | -1971.88% |
| Align Technology, Inc. | 3.86 Billion USD | -139.549% |
| Elevance Health Inc. | 171.34 Billion USD | 94.6% |
| AxoGen, Inc. | 159.01 Million USD | -5718.429% |
| Boston Scientific Corporation | 14.24 Billion USD | 35.028% |
| CVS Health Corporation | 357.77 Billion USD | 97.414% |
| Cardinal Health, Inc. | 226.82 Billion USD | 95.921% |
| Centene Corporation | 141.26 Billion USD | 93.451% |
| DaVita Inc. | 12.14 Billion USD | 23.79% |
| HCA Healthcare, Inc. | 64.96 Billion USD | 85.759% |
| Hologic, Inc. | 4.03 Billion USD | -129.561% |
| Humana Inc. | 106.37 Billion USD | 91.302% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | -152.721% |
| Laboratory Corporation of America Holdings | 12.16 Billion USD | 23.924% |
| Masimo Corporation | 2.04 Billion USD | -351.736% |
| McKesson Corporation | 308.95 Billion USD | 97.005% |
| Patterson Companies, Inc. | 6.56 Billion USD | -40.859% |
| ResMed Inc. | 4.68 Billion USD | -97.469% |
| Henry Schein, Inc. | 12.33 Billion USD | 25.018% |
| Teladoc Health, Inc. | 2.6 Billion USD | -255.516% |
| Universal Health Services, Inc. | 14.28 Billion USD | 35.219% |
| Veeva Systems Inc. | 2.36 Billion USD | -291.425% |
| Baxter International Inc. | 14.81 Billion USD | 37.541% |
| Becton, Dickinson and Company | 19.37 Billion USD | 52.24% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | -29.869% |
| Danaher Corporation | 23.89 Billion USD | 61.272% |
| Stryker Corporation | 20.49 Billion USD | 54.864% |
| Medtronic plc | 32.36 Billion USD | 71.413% |